BayMedica
BayMedica is a wholesale supplier of six minor cannabinoid isolates (CBC, THCV, CBDV, CBTC, CBG, CBL) serving CPG, nutraceutical, and contract manufacturers via distribution partners. This InMed Pharmaceuticals subsidiary is winding down commercial operations by June 30, 2026 due to H.R. 5371.
- Company typePrivate
- Founded2016
- HeadquartersIncline Village, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BayMedica does
BayMedica is a U.S.-based wholesale supplier of rare and minor cannabinoids operating as a wholly owned subsidiary of InMed Pharmaceuticals (NASDAQ: INM). The company produces and distributes six minor cannabinoid isolates — CBC (Cannabichromene), THCV (Tetrahydrocannabivarin), CBDV (Cannabidivarin), CBTC (Cannabicitran), CBG (Cannabigerol), and CBL (Cannabicyclol) — to CPG brands, contract manufacturers, nutraceutical companies, beverage formulators, and product developers in the cannabis, hemp, and wellness industries. Its end customers incorporate these ingredients into functional beverages, gummies, supplements, nootropics, and cosmetics.
The company operates a platform-agnostic manufacturing system spanning chemical synthesis, semi-synthesis, plant extraction, and validated precision fermentation, enabling customers to select production routes based on brand positioning, regulatory requirements, and cost-efficiency while maintaining consistent purity and quality. All production runs under food-grade cGMP standards aligned with 21 CFR 111 and 117, with each batch tested internally and by two independent third-party laboratories delivering dual Certificates of Analysis, full batch traceability, overfill guarantees, and zero-THC verification. BayMedica employs 1–10 people across an R&D site in South San Francisco, California and a U.S. operations office in Incline Village, Nevada.
Commercially, BayMedica generates revenue through wholesale bulk transactions routed via a network of three named distribution partners — Laurelcrest, Low Gravity Hemp, and Red Mesa Science — with pricing undisclosed and structured as one-time take-rate transactions. In March 2026, parent InMed Pharmaceuticals' board ratified the wind-down of BayMedica's commercial operations by June 30, 2026 in response to anticipated material negative impacts from U.S. federal legislation H.R. 5371 (effective November 12, 2026). Q2 FY2026 revenue was $0.8 million, down 26% year-over-year.
BayMedica firmographics
Firmographics- Name
- BayMedica
- Legal name
- BayMedica, LLC
- Website
- https://baymedica.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BayMedica is a wholesale supplier of six minor cannabinoid isolates (CBC, THCV, CBDV, CBTC, CBG, CBL) serving CPG, nutraceutical, and contract manufacturers via distribution partners. This InMed Pharmaceuticals subsidiary is winding down commercial operations by June 30, 2026 due to H.R. 5371.
- Ownership category
- akta.pro rank
BayMedica industry classification
Industry- Product category
- Cannabinoid Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal) (CRANAHAD)
Keywords
Where BayMedica is headquartered
LocationHeadquarters
- HQ city
- Incline Village
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
BayMedica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Wholesale Minor Cannabinoids: BayMedica sells minor cannabinoid isolates (CBC, THCV, CBDV, CBTC, CBG, CBL) at wholesale and bulk quantities to CPG brands, product developers, and manufacturers. Revenue generated through one-time bulk transactions with distribution partners worldwide.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Wholesale and bulk minor cannabinoids available through trusted distribution partners |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
BayMedica product offering
Product offeringCore offering
BayMedica manufactures and wholesale-distributes minor cannabinoid isolates (CBC, THCV, CBDV, CBTC, CBG, and CBL) to CPG brands, product developers, and nutraceutical manufacturers. Production occurs through a platform-agnostic system combining chemical synthesis, semi-synthesis, plant extraction, and precision fermentation under food-grade cGMP standards, with rigorous batch traceability and dual third-party Certificates of Analysis.
Product overview
BayMedica is a B2B wholesale supplier of rare and minor cannabinoids operating as a division of InMed Pharmaceuticals. The company offers a portfolio of six minor cannabinoid isolates (CBC, THCV, CBDV, CBTC, CBG, and CBL) as wholesale and bulk ingredients for product developers and brands in the consumer packaged goods, nutraceutical, and wellness industries. These cannabinoids are produced through a multi-platform manufacturing system combining chemical synthesis, semi-synthesis, plant extraction, and precision fermentation. The product portfolio emphasizes non-intoxicating, bioidentical compounds produced under food-grade cGMP standards with rigorous quality testing and batch traceability.
Differentiator
Problem solved
Functional benefit
Products and services
- CBC (Cannabichromene)
Companies that use BayMedica
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
BayMedica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
BayMedica partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- LaurelcrestcoreDistribution partner enabling access to BayMedica minor cannabinoids for brands and product developers in the cannabis and hemp industry.
- Low Gravity HempcoreDistribution partner for BayMedica minor cannabinoids serving the hemp-derived product market.
- Red Mesa SciencecoreDistribution partner providing BayMedica minor cannabinoid ingredients to science-focused cannabis companies.
Scale indicators1 record
Recent moves5 records
Expansion highlights2 records
BayMedica competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
BayMedica social profiles
Digital presenceBayMedica compliance and trust
Trust signalCompliance2 records
BayMedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
BayMedica leadership team
Management profileNumber of profiles
Profiles4 records
BayMedica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BayMedica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BayMedica
What does BayMedica do?
BayMedica manufactures and wholesale-distributes minor cannabinoid isolates (CBC, THCV, CBDV, CBTC, CBG, and CBL) to CPG brands, product developers, and nutraceutical manufacturers. Production occurs through a platform-agnostic system combining chemical synthesis, semi-synthesis, plant extraction, and precision fermentation under food-grade cGMP standards, with rigorous batch traceability and dual third-party Certificates of Analysis.
Is BayMedica a public or private company?
BayMedica is a private company. It is classified as corporate owned and is currently operating.
When was BayMedica founded?
BayMedica was founded in 2016. It employs 1 to 10 people.
Where is BayMedica based?
BayMedica is headquartered in Incline Village, United States, in the North America region.
How does BayMedica make money?
One revenue line is on record: wholesale Minor Cannabinoids.
Does BayMedica have an API?
No public API is recorded for BayMedica.
What industry is BayMedica in?
BayMedica's product category is Cannabinoid Ingredients. Its primary akta.pro industry code is CRANAHAD, Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal). Its NAICS code is 325411 and its SIC code is 2833.